Skip to main content
Log in

Vorhersage von Tumorrezidiv und Progress beim oberflächlichen Blasenkarzinom durch Verwendung eines künstlichen neuronalen Netzwerkes (ANN)

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Robert Koch Institut: Interaktive Datenbankabfrage auf http://www.rki.de

  2. Kurth KH, Denis L, Bouffioux Ch et al. (1995) Factors affecting recurrence and progression in superficial bladder tumours. Eur J Cancer 31A: 1840–1846

    Article  PubMed  CAS  Google Scholar 

  3. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J et al. (2000) Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol 164: 680–684

    Article  PubMed  CAS  Google Scholar 

  4. Esrig D, Spruck CH, Nichols PW et al. (1993) P53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer. Am J Pathol 143: 1389–1397

    PubMed  CAS  Google Scholar 

  5. Sarkis AS, Dalbagni G, Cordon-Cardo C et al. (1993) Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 85: 53–59

    Article  PubMed  CAS  Google Scholar 

  6. Neal DE, Sharples L, Smith K et al. (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65: 1619

    Article  PubMed  CAS  Google Scholar 

  7. Sato K, Moriyama M, Mori S et al. (1992) An immunohistologic evaluation of c-erbB-2 gene product in patients with urinary bladder carcinoma. Cancer 70: 2493

    Article  PubMed  CAS  Google Scholar 

  8. Yates DR, Rehman I, Abbod MF et al. (2007) Promoter hypermethilation identifies progression risk in bladder cancer. Clin Cancer Res 13: 2046–2053

    Article  PubMed  CAS  Google Scholar 

  9. Yin W, Chen N, Zhang Y et al. (2006) Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder. Mod Pathol 19: 1487–1497

    PubMed  CAS  Google Scholar 

  10. Planz B, Deix T, Draxler V et al. (2003) Doimmuno histochemical markers increase outcome pudiction of a neural network for patarots with bladder cancer. Eur J Urol Suppl

  11. Burke HB, Goodman PH, Rosen DB et al. (1997) Artificial neural networks improve the accuracy of cancer survival prediction. Cancer (Phila) 79: 857–862

    Google Scholar 

  12. Zlotta AR, Remzi M, Snow PB et al. (2003) An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng/ml or less. J Urol 169: 1724–1728

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Planz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Planz, B., Deix, T. & Caspers, H. Vorhersage von Tumorrezidiv und Progress beim oberflächlichen Blasenkarzinom durch Verwendung eines künstlichen neuronalen Netzwerkes (ANN). Urologe 46, 1138–1139 (2007). https://doi.org/10.1007/s00120-007-1465-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-007-1465-8

Navigation